Heterologous Expression of Xenobiotic Mammalian-Metabolizing Enzymes in Mutagenicity Tester Bacteria: An Update and Practical Considerations

References

• Guengerich, F. P. 1992. Metabolic activation of carcino- gens. Pharmac. Ther., 54: 17–61.
   PubMed Web of Science ®Google Scholar
• Gonzalez, F. J. and Gelboin, H. V. 1994. Role of human cytochrome P450 in the metabolic activation of chemi- cal carcinogens and toxins. Drug Chem. Rev. 26: 165–183.
   PubMed Web of Science ®Google Scholar
• Vermeulen, N. P. E. 1996. Role of metabolism in chemi- cal toxicity. In: C. Ioannides, (Ed.) Cytochrome P450: Metabolic and Toxicological Aspects, CRC Press, Boca Raton, FL, pp. 29–53
   Google Scholar
• Miller, E. C. and Miller, J. A. 1981. Searches for ultimate carcinogens and their reaction with cellular macro- molecules. Cancer 47: 2327–2345
   PubMed Web of Science ®Google Scholar
• Langenbach, R., Smith, P. B. and Crespi, C. 1992. Re- combinant DNA approaches for the development of metabolic systems used in in vitro toxicology. Mutat. Res. 277: 251–275.
   PubMed Web of Science ®Google Scholar
• Bridges, J. W. and Hubbard, S. A. 1980. Problems in providing an appropriate drug metabolizing system for short-term tests for carcinogens. In: The Predictive Value of Short-Term Screening Tests in Carcinoge- nicity Evaluation, G. M. Wialliams, R. Kroes, H. W. Waaijers, and K. W. van de Poll, Elsevier, Amsterdam, pp. 69–88.
   Google Scholar
• Rueff, J., Chiapella, C., Chipman, J. K., Darroudi, F., Duarte Silva, I., Duverger-van Bogaert, M., Fonti, E., Glatt, H. R., Isern, P., Laires, A., Llagosterra, M., Mossesso, P., Natarajan, A. T., Palitti, F., Rodrigues, A.S., Schinoppi, A., Turchi, G., and Werle-Schneider, G. 1996. Development and validation of alternative metabolic systems for mutagenicity testing in short- term assays. Mutat. Res. 353: 151–176.
   PubMed Web of Science ®Google Scholar
• Gonzalez, F. J., Crespi, C. L., and Gelboin, H. V. 1991. cDNA-expressed human cytochrome P450s: a new age of molecular toxicology and human risk assess- ment. Mutat. Res., 247: 113–127.
   PubMed Web of Science ®Google Scholar
• Simula, A. P., Crichton, M. B., Black, S. M., Pemble, S., Bligh, H. F. J., Beggs, J. D. and Wolf, C. R. 1993. Heterologous experession of drug-metabolizing enzymes in cellular and whole animal models. Toxicol- ogy 82: 3–20.
   Google Scholar
• Guengerich, F. P., Gillam, E. M. J. and Shimada, T. 1996. New applications of bacterial systems in prob- lems in toxicology. Crit. Rev. Toxicol. 26: 551–583.
   PubMed Web of Science ®Google Scholar
• Josephy, P. D., Gruz, P., and Nohmi, T. 1997. Recent advances in the construction of bacterial genotoxicity assays. Mutat. Res. 386: 1–23.
   PubMed Web of Science ®Google Scholar
• Sengstag, C., Werbel, B. and Fasullo, M. 1996. Genotoxicity of aflatoxin B1: evidence for recombi- nation-mediated mechanism in S. cerevisiae. Cancer Res. 56: 5457–5465.
   Google Scholar
• Glatt, H. R. and Gemperlein, I. 1987. Search for cell culture with diverse xenobiotic-metabolizing activi- ties and their use in toxicology studies. Mol. Toxicol. 1, 313–334.
   PubMedGoogle Scholar
• Gonzalez, F. J. and Korzekwa, K. R. 1994. Cytochromes P450 expression systems. Annu. Rev. Pharmacol. Toxicol. 35, 369–390.
   Web of Science ®Google Scholar
• Shapiro, L., Kaiser, D., and Losick, R. 1993. Develop- ment and behaviour in bacteria. Cell, 73, 835–836.
   PubMedGoogle Scholar
• Barnes D. E., Lindahl, T., and Segwick, B. 1993. DNA repair. Curr. Opin. Cell Biol. 5: 424–433.
   PubMed Web of Science ®Google Scholar
• Venitt, S., Bartsch, H., Becking, G., Fuchs, R. P. P., Hofnung, M., Malaveille, C., Matsushima, T., Rajewsky, M. R., Roberfroid, M., and Rosenkranz, H. S. 1986. Short-term assays using bacteria. In: Long- Term and Short-Term Assays for Carcinogens: A Critical Appraisal. IARC Scientific Publications, no. 83, Lyon, Chap. 5, Oxford University Press, Oxford, UK, pp. 143–156.
   Google Scholar
• Guengerich, F. P. 1988. Roles of cytochrome P450 en- zymes in chemical carcinogens and cancer chemo- therapy. Cancer Res. 48: 2946–2954.
   PubMed Web of Science ®Google Scholar
• Austin, E. A., Graves, J. M., Hite, L. A., Parker, C. T., and Schnaitman, C. A. 1990. Genetic analyses of lipopolysaccharide core biosynthesis by Escherichia coli K12: insertion mutagenesis of th rfa locus. J. Bacteriol. 172: 5312–5325.
   PubMed Web of Science ®Google Scholar
• Parker C. T., Kloser A. W., Schnaitman C. A., Stein M. A., Gottesman, S., and Gibson, B. W. 1992. Role of the rfaG and rfaP genes in determining the lipopolysac- charide core structure and cell surface properties of Escherichia coli. J. Bacteriol. 174: 2525–2538.
   PubMed Web of Science ®Google Scholar
• Anderson, D. 1995. Genotoxicity assays. In: Molecular Aspects of Oxidative Drug Metabolizing Enzymes. Arinç, E., Schenkman, J. B., and Hodgson, E., Eds., NATO ASI Series, Vol. H90, Springer-Verlag, Ber- lin, pp. 303–396.
   Google Scholar
• Friedberg, E. C., Walker, G. C. and Siede, W. 1995. DNA Repair and Mutagenesis, ASM Press, Washing- ton, DC, pp. 407–464.
   Google Scholar
• Friedberg, E. C., Walker, G. C., and Siede, W. 1995. DNA Repair and Mutagenesis, ASM Press, Washing- ton, DC, pp. 465–522.
   Google Scholar
• Langer, P. J., Shanabruch, W. G., and Walker, G. C. 1981. Functional organization of plasmid pKM101. J. Bacteriol., 145: 1310–1316.
   PubMed Web of Science ®Google Scholar
• Hauser, J., Levine, A. S., Ennis, D. G., Chumakov, K. M., and Woodgate, R. 1992. The enhanced mutagenic potential of the MucAB proteins correlates with the highly efficent processing of the MucA protein. J. Bacteriol. 174: 6844–6851.
   PubMed Web of Science ®Google Scholar
• Bintz, R. and Fuchs, R. P. P. 1990. Induction of -2 frameshift mutations within alternating GC sequences by carcinogens that bind to the C8 position of guanine residues: development of a specific mutation assay. Mol. Gen. Genet. 221: 331–338.
   PubMedGoogle Scholar
• Ruiz-Rubio, M., Alejandre-Duran, E., and Pueyo, C. 1985. Oxidative mutagens specific for AT base pairs induce forward mutations to L-arabinose resistance in Salmonella typhimurium. Mutat. Res. 147: 153–163.
   PubMed Web of Science ®Google Scholar
• Maron, D. M. and Ames, B. N. 1983. Revised methods for Salmonella mutagenicity test. Mutat. Res. 113: 173–215.
   PubMed Web of Science ®Google Scholar
• Quillardet, P. and Hofnung, M. 1985. The SOS Chromotest, a colorimetric bacterial assay for genotoxins: procedures. Mutat. Res. 147: 65–78.
   PubMed Web of Science ®Google Scholar
• Oda, Y., Nakamura, S., Oki, I., Kato, T., and Shinagawa, H. 1985. Evaluation of the new system (umu-test) for the detection of environmental mutagens and carcino- gens. Mutat. Res. 147: 219–299.
   PubMed Web of Science ®Google Scholar
• Friedberg, T. 1998. Molecular biological methods for characterising drug-metabolizing enzymes in hepatic and extrahepatic tissues. Skin Pharmacol. Appl. Skin Physiol., 11: 61–69.
   PubMedGoogle Scholar
• Kranendonk, M., Mesquita, P., Laires, A., Vermeulen, N. P. E., and Rueff, J. 1998. Expression of human cytochrome P450 1A2 in Escherichia coli: a system for biotransformation and genotoxicity studies of chemical carcinogens. Mutagenesis 3: 263–269.
   Google Scholar
• Wormhoudt, L. W., Commandeur, J. N. M., and Vermeulen, N. P. E. 1998. Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glu- tathione-S-transferase and epoxide hydrolase enzymes. Crit. Rev. Toxicol. 29: 59–124.
   Web of Science ®Google Scholar
• Glatt, H., Bartsch, I., Cristoph, S., Coughtrie, M. W. H., Falany, C. N., Hagen, M., Landsriedel, R., Pabel, U., Phillips, D. H., Seidel, A., and Yasushi, Y. 1998. Sulfotransferase-mediated activation of mutagens stud- ied using heterologous expression systems. Chem. Biol. Interact. 109: 195–219.
   PubMed Web of Science ®Google Scholar
• Guengerich, F. P. 1997. Comparison of catalytic selec- tivity of cytochrome P450 subfamily enzymes from different species. Chem. Biol. Interact. 106, 161–182.
   PubMed Web of Science ®Google Scholar
• Gonzalez, F. 1995. Genetic polymorphism and cancer susceptibility: fourteenth Sapporo cancer seminar. Cancer Res., 55: 710–715.
   PubMed Web of Science ®Google Scholar
• Guengerich, F. P. 1996. In vitro techniques for studying drug metabolism. J. Pharmacokin. Biopharm. 24: 521– 533.
   PubMedGoogle Scholar
• Sawada, M. and Kamataki, T. 1998. Genetically engi- neered cells stably expressing cytochrome P450 and their application to mutagens assay. Mutat. Res. 411: 19–43.
   PubMed Web of Science ®Google Scholar
• Parikh, A., Gilliam, M. J. and Guengerich, F. P. 1997. Drug metabolism by Escherichia coli expressing hu- man cytochrome P450. Nature Biotech. 15: 784–788.
   PubMed Web of Science ®Google Scholar
• Shimada, T., Gillam, E. M. J., Sandhu, P., Guo, Z., Tukey, R. H., and Guengerich, F. P. 1994. Activation of procarcinogens by human cytochrome P450 en- zymes expressed in Escherichia coli. Simplified bac- terial systems for genotoxocity assays. Carcinogen- esis 15: 2523–2529.
   Google Scholar
• Yamazaki, H., Inui, Y., Wrighton, S. A., Guengerich, F. P., and Shimada, T. 1995. Procarcinogen activation by cytochrome P450 3A4 and 3A5 expressed in Es- cherichia coli and by human liver microsomes. Car- cinogenesis 16: 2167–2170.
   PubMed Web of Science ®Google Scholar
• Commandeur, J. N. M., Stijntjes, G. J., and Vermeulen, N. P. E. 1995. Enzymes and transport systems in- volved in the formation and disposition of glutathione- S-conjugates. Role in bioactivation and detoxication mechanisms of xenobiotics. Pharmacol. Rev. 47: 271– 330.
   PubMed Web of Science ®Google Scholar
• Van der Aar, E. M., Tan, K. T., Commandeur, J. N. M., and Vermeulen, N. P. E. 1998. Strategies to characterise the mechanisms of action and the active sites of glu- tathione-S-transferases: a review. Drug Metab. Rev. 30: 569–643.
   PubMed Web of Science ®Google Scholar
• Thier, R., Taylor, J. B., Pemble, S. E., Humphreys, W. G., Persmark, M., Ketterer, B., and Guengerich, F. P. 1993. Expression of mammalian glutathione-S-trans- ferase 5-5 in Salmonella typhimurium TA1535 leads to base-pair mutations upon exposure to dihalomethanes. Proc. Natl. Acad. Sci. U.S.A. 90: 8576–8580.
   PubMed Web of Science ®Google Scholar
• Oda, Y., Yamazaki, H., Their, R., Ketterer, B., Guengerich, F. P., and Shimada, T. 1996. A new Salmonella typhimurium NM5004 strain expressing rat glutathione-S-transferase 5-5: use in detection of genotoxicity of dihaloalkanes using an SOS/umu test system. Carcinogenesis 17: 297–302.
   PubMed Web of Science ®Google Scholar
• Shimada, T., Yamazaki, H., Oda, Y., Hiratsuka, A., Watabe, T., and Guengerich, F. P. 1996. Activation and inactivation of carcinogenic dihaloalkanes and other compounds by glutathione-S-transferase 5-5 in Salmonella typhimurium tester strain NM5004. Chem. Res. Toxicol. 9: 333–340.
   PubMed Web of Science ®Google Scholar
• Thier, R., Muller, M., Taylor, J. B., Pemble, S. E., Ketterer, B., and Guengerich, F. P. 1995. Enhance- ment of bacterial mutagencity of bifunctional alkylat- ing agents by expression of mammalian glutathione- S-transferase. Chem. Res. Toxicol. 8: 465–472.
   PubMed Web of Science ®Google Scholar
• Simula, A. P., Glancey, M. J., and Wolf, C. R. 1993. Human glutathione–S-transferase-expressing Salmo- nella typhimurium tester strains to study the activa- tion/detoxification of mutagenic compounds: studies with halogenated compounds, aromatic amines and aflatoxin B1. Carcinogensis 14: 1371–1376.
   PubMed Web of Science ®Google Scholar
• Simula, A. P., Glancey, M. J., Soderlund, E. J., Dybing, E., and Wolf, C.R. 1993. Increased mutagenicity of 1,2-dibromo-3-chloropropane and tris(2,3- bibromopropyl)posphate in Salmonella TA100 ex- pressing human glutathione–S-transferases. Carcino- genesis 14, 2303–2307.
   PubMed Web of Science ®Google Scholar
• Thier, R., Pemble, S. E., Kramer, H., Taylor, J. B., Guengerich, F. P., and Ketterer, B. 1996. Human glutathione-S-transferase T1-1 enhances mutagenic- ity of 1,2-dibromoethane and 1,2,3,4-diepoxybutane in Salmonella typhimurium. <i>Carcinogenesis17: 163–166.
   Google Scholar
• Evans, D. A. 1989. N-acetyltransferase. Pharmacol. Ther. 42: 157–239.
   PubMed Web of Science ®Google Scholar
• Kato, R. and Yamazoe, Y. 1994. Metabolic activation of N-hydroxylated metabolites of carcinogenic and mu- tagenic arylamines and arylamides by esterification. Drug Metab. Rev. 26: 413–430.
   PubMed Web of Science ®Google Scholar
• Grant, D. M., Josephy, P. D., Lord, H. L., and Morrison, L. D. 1992. Salmonella typhimurium strains express- ing human arylamine N-acetyltransferases: metabo- lism and mutagenic activation of aromatic amines. Cancer Res. 52: 3961–3964.
   PubMed Web of Science ®Google Scholar
• Watanabe, B., Nohmi, T., and Ishidate M., Jr. 1987. New tester strains of Salmonella typhimurium highly sensi- tive to mutagenic nitroarenes. Biochem. Biophys. Res. Commun. 147: 974–979.
   PubMed Web of Science ®Google Scholar
• Wild, D., Feser, W., Michel, S., Lord, H. L. and Josephy, D. 1995. Metabolic activation of heterocyclic aro- matic amines catalyzed by human arylamine N- acetyltransferase isoenzymes (NAT1 and NAT2) ex- pressed in Salmonellla typhimurium. <i>Carcinogenesis16: 643–648.
   Google Scholar
• Josephy, D. P., Debruin, L. S., Lord, H. L., Oak, J. N., Evans, D. H., Guo, Z., Dong, M., and Guengerich, F. 1995. Bioactivation of aromatic amines by recom- binant human cytochrome P4501A2 expressed in Ames tester strain bacteria: a substitute for activation by mammalian tissue preparations. Cancer Res., 55: 799– 802.
   PubMed Web of Science ®Google Scholar
• Josephy, P. D., Evans, D. H., Parikh, A., and Guengerich, F. P. 1998. Metabolic activation of aromatic amine mutagens by simultaneous expression of human cyto- chrome P450 1A2, NADPH cytochrome P450 reduc- tase and N-acetyltransferase in Escherichia coli. Chem. <i>Res. Toxicol. 11: 70–74.
   Google Scholar
• Suzuki, A., Kushida, H., Iwata, H., Watanabe, M., Nohmi, T., Fujita, K., Gonzalez, F. J., and Kamataki, T. 1998. Establishment of a Salmonella tester strain highly sensitive to mutagenic heterocylic amines. Cancer Res. 58: 1833–1838.
   PubMed Web of Science ®Google Scholar
• Kranendonk, M., Fisher, C. W., Roda, R., Carreira, F., Theisen, P., Laires, A., Rueff, J., Vermeulen, N. P. E., and Estabrook, R. W. 1999. Escherichia coli MTC, a NADPH cytochrome P450 reductase competent mu- tagenicity tester strain for the expression of human cytochrome P450: comparison of three types of ex- pression systems. Mutat. Res. 439: 287–300.
   PubMed Web of Science ®Google Scholar
• Jenkins, C. M. and Waterman, M. R. 1994. Flavodoxin and NADPH flavodoxin reductase from Escherichia coli support bovine cytochrome P450c17 hydroxylase activities. J. Biol. Chem. 269: 27401–27408.
   PubMed Web of Science ®Google Scholar
• Jenkins, C. M. and Waterman, M. R. 1998. NADPH- flavodoxin reductase and flavodoxin from Escheri- chia coli: characteristics as a soluble microsomal P450 reductase. Biochemistry 37: 6106–6113.
   PubMed Web of Science ®Google Scholar
• Kranendonk, M., Ruas, M., Laires, A., and Rueff, J. 1994. Isolation and prevalidation of an Escherichia coli tester strain for the use in mechanistic and meta- bolic studies of genotoxins. Mutat. Res., 312: 99–109.
   PubMedGoogle Scholar
• Kranendonk, M., Pintado, F., Mesquita, P., Laires, A., Vermeulen, N. P. E., and Rueff, J. 1996. MX100, a new Escherichia coli tester strain for use in genotoxicity studies. Mutagenesis 11: 327–333.
   PubMed Web of Science ®Google Scholar
• Kranendonk, M., Roda, R., Carreira, F., Theisen, P., Laires, A., Fisher, C. W., Rueff, J., Vermeulen, N. P. E., and Estabrook, R. W. 1999. Escherichia coli MTC, a NADPH cytochrome P450 reductase competent mu- tagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4 or 3A5: catalytic activities and mutagenicity studies. Mutat. Res. 441: 73–83.
   PubMed Web of Science ®Google Scholar
• Glatt, H. R. 1997. Bioactivation of mutagens via sulfation. FASEB J. 11, 314–321.
   PubMed Web of Science ®Google Scholar
• Miller, J. A. 1994. Sulfonation in chemical carcinogen- esis — history and present status. Chem. Biol. Inter- act. 92: 329–341.
   PubMed Web of Science ®Google Scholar
• Meerman, J. H., Ringer D. P., Coughtrie, M. W., Bamforth, K. J., and Gilissen, R.A. 1994. Sulfation of carcinogenic aromatic hydroxylamines and hydroxamic acids by rat and human sulfotransferases: substrate specificity, developmental aspects and sex differences. Chem. Biol. Interact. 92: 321–328.
   PubMed Web of Science ®Google Scholar
• Gilissen, R. A., Bamforth, K. J., Stavenuiter, J. F., Coughtrie, M. W., and Meerman, J. H. 1994. Sulfation of aromatic hydroxyamic acids and hydroxylamines by multiple forms of human liver sulfotransferases. Carcinogenesis 15: 39–45.
   PubMed Web of Science ®Google Scholar
• Surh, Y-J., Liem, A., Miller, E. C. and Miller, J. A. 1989. Metabolic activation of the carcinogen 6- hydroxymethybenzo[a]pyrene: formation of an elec- trophilic sulfuric acid ester and benzylic DNA ad- ducts in rat liver in vivo and in reactions in vitro. Carcinogenesis 10: 1519–1528.
   Google Scholar
• Fisher, C. W., Caudle, D. L., Martin-Wixtrom, C., Quattrochi, L. C., Tukey, R. H., Waterman, M. R., and Estabrook, W. R. 1992. High-level expression of functional human cytochrome P450 1A2 in Escheri- chia coli. FASEB J. 6: 759–764.
   PubMed Web of Science ®Google Scholar
• Kranendonk, M., Ruas, M., Laires, A., and Rueff, J. 1994. Isolation and prevalidation of an Escherichia coli tester strain for genotoxins. In: Lechner M. C., Ed. Cyto- chrome P450, Biochemistry, Biophysics and Molecular Biology, Jonny Libbey Eurotext, Paris, pp. 741–744.
   Google Scholar
• Lampel, K. L. and Riley 1982. Discontinuity of homol- ogy of Escherichia coli and Salmonella typhimurium DNA in the lac region. Mol. Gen. Genet. 186: 82–86.
   PubMedGoogle Scholar
• Porter,T. D., Wilson, T. E., and Kasper, C. B. 1987. Expression of a functional 78,000 dalton mammalian flavoprotein, NADPH-cytochrome P450 oxidoreduc- tase, in Escherichia coli. Arch. Biochem. Biophys. 254: 353– 367.
   Google Scholar
• Barnes, H. J. 1996. Maximizing expression of eukary- otic cytochrome P450s in Escherichia coli. Meth. Enzymol. 272: 3–14.
   PubMed Web of Science ®Google Scholar
• Pritchard, M. P., Ossetian, R., Li, D. N., Henderson, C. J., Burchell, B., Wolf, C. R., and Friedberg, T. 1997. A general strategy for the expression of recombinant human cytochrome P450s in Escherichia coli using bacterial signal peptides: expression of CYP3A4, CYP2A6, and CYP2E1. Arch. Biochem. Biophys. 345: 342–354.
   PubMed Web of Science ®Google Scholar
• Shen, A. L., Porter, T. D., Wilson, T. E., and Kaspar, C. 1989. Structural analysis of the FMN binding do- main of NADPH-cytochrome P450 oxidoreductase by site-mutagenesis. J. Biol. Chem. 264: 7584–7589.
   PubMed Web of Science ®Google Scholar
• Pillot, T., Ouzinne, M., Fournel-Gigleux, S., Lafaurie, C., Radominska, A., Lester, R., Drake, R., Treat, S., Siest, G., and Magdalou, J. 1993. Purification and characterization of a catalytically active human liver UDP-glucuronosyltransferase expressed as a fusion protein in E. coli. Biochem Biophys. Res. Comm. 196: 473–479.
   Google Scholar
• Kier, L. E., Brusick, D. J., Auketta, A. E., Von Halle, E. S., Brown, M. M., Simmon, V. F., Dunkel, V., McCann, J., Moertelmans, K., Prival, M., Roa, T. K., and Ray, V. 1986. The Salmonella typhimurium/mammalian mi- crosomal assay. A report of the US Environmental Protection Agency Gene-Tox Program. Mutat.Res. 168: 69–240.
   Google Scholar
• MacPhee, D. G. 1989. Development of bacterial mutage- nicity tests: a view form afar. Environ. Molec. Mu- tagen. 14 (Suppl.) 16: 35–38.
   Google Scholar
• Sedgwick, S. G., Ho, C., and Woodgate, R. 1991. Mu- tagenic DNA repair in enterobacteria. J. Bacteriol. 173: 5604–5611.
   PubMed Web of Science ®Google Scholar
• Hagen, M., Pabel., U., Landsiedel, R., Bartsch, I., Falany,C N., and Glatt, H. 1998. Expression of human estro- gen sulfotransferase in Salmonella typhimurium: dif- ferences between hHST and hEST in the enantioselective activation of 1-hydroxyethylpyrene to a mutagen. Chem. Biol. Interact. 109: 249–253.
   Google Scholar
• Buchner, J. and Rudolf, R. 1991. Routes to active pro- teins from transformed microorganisms. Curr. Opin. Biotechnol. 2: 532–538.
   PubMed Web of Science ®Google Scholar
• Langer, P. J., Perry, K. L., and Walker, G. C. 1985. Complementation of a pKM101 derivative that de- creases resistance to UV killing but increases suscep- tibility to mutagenesis. Mutat. Res. 150: 147–158.
   PubMedGoogle Scholar
• Brosius, J. and Holy, A. 1984. Regulation of ribosomal RNA promotors with a synthetic lac operator. Proc. Natl. Acad. Sci. U.S.A., 81: 6929–6933.
   PubMed Web of Science ®Google Scholar
• Sambrook, J., Fritsch, T. F., and Maniatis, T. 1989. Mo- lecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
   Google Scholar
• Callen, D. F. 1978. A review of the metabolism of xenobiotica by microorganisms with relation to short- term test systems for environmental carcinogens. Mutat. Res. 55: 153–163.
   PubMedGoogle Scholar
• Laires, A., Pacheco, P., and Rueff, J. 1989. Mutagenicity of rutin and the glycosidic activity of cultured cell-free microbial preparations of human faeces and saliva. Fd. Chem. Toxic. 27: 437–443.
   PubMed Web of Science ®Google Scholar
• McCoy, E. C., Anders, M., and Rosenkranz, H. S. 1983. The basis of the insensitivity of Salmonella typhimurium strain TA98/1,8-DNP to the mutagenic action of nitroarenes. Mutat. Res. 121: 17–23. Prieto-Alamo, M. J., Abril, N., and Pueyo, C. 1993. Mutagenesis in Escherichia coli K12 mutants defec- tive in superoxide dismutase or catalase. Carcinogen- esis 14: 237–244.
   Google Scholar
• Watanabe, M., Ishidate, M., Jr., and Nohmi, T. 1989. A sensitive method for the detection of mutagenic nitroarenes: construction of nitroreductase-overpro- ducing derivatives of Salmonella typhimurium strains TA98 and TA100. Mutat. Res. 216: 211–220.
   PubMedGoogle Scholar
• Kranendonk, M., Commandeur, J. N. M., Laires, A., Rueff, J., and Vermeulen, N. P. E. 1997. Characterisation of enzyme activities and cofactors involved in bioactivation and bioinactivation of chemi- cal carcinogens in the tester strains Escherichia coli K12 MX100 and Salmonella typhimurium LT2 TA100. Mutagenesis 12: 245–254.
   PubMed Web of Science ®Google Scholar
• Watanabe, B., Matsuoka, A., Yamazaki, N., Hayashi, M., Deguchi, T., Nohmi, T., and Sofuni, T. 1994. New sublines of Chinese hamster CHL stably expressing human NAT1 and NAT2 N-acetyltransferases or Sal- monella typhimurium O-acetyltransferase: compari- son of the sensitivity to nitroarenes and aromatic amines using the in vitro micronucleus test. Cancer Res. 54: 1672–1677.
   PubMed Web of Science ®Google Scholar
• Stevens, G. J., LaVoie, E. J., and McQueen, C. A. 1996. The role of actylation in the mutagenicity of the anti- tumor agent, batracyclin. Carcinogenesis 17: 115– 119.
   PubMed Web of Science ®Google Scholar
• Woodward, S. I. and Dailey, H. A. 1995. Regulation of heme biosynthesis in Escherichia coli. Arch. Biochem. Biophys. 316: 110–115.
   Google Scholar
• Yamazaki, H., Nkajima, M., Nakamura, M., Asahi, S., Shimada, N., Gillam, E. M. J., Guengerich, F. P., Shimada, T., and Yokoi, T. 1999. Enhancement of cytochrome P450 3A4 catalytic activities by cyto- chrome b5 in bacterial membranes. Drug Metab. Dipos. 27: 999–1004.
   PubMed Web of Science ®Google Scholar
• Voice, M. W., Zhang, Y., Wolf, C. R., Burchell, B., and Friedberg, T. 1999. Effects of human cytochrome b5 on CYP3A4 activity and stability in vivo. Arch. Biochem. Biophys. 366: 116–124.
   Google Scholar
• McGinnity D. F., Griffin, S. J., Moody, G. C., Voice, M., Hanlon, S., Friedberg, T., and Riley, R. J. 1999. Rapid characterization of the major drug-metabolizing hu- man hepatic cytochrome P450 enzymes expressed in Escherichia coli. Drug Metab. Dispos. 27: 1017–1023.
   PubMed Web of Science ®Google Scholar
• Friedberg, T. and Wolf, C. R. 1996. Recombinant tech- nology as an investigative tool in drug metabolism research. Adv. Drug Deliv. Rev., 22: 187–213.
   Web of Science ®Google Scholar
• Service, R. F. 1996. Combinatorial chemistry hits the drug market. Science 272: 1266–1268.
   PubMed Web of Science ®Google Scholar
• Knehr, M., Thomass, H., Arand, M., Gebel, T., Zeller, H-D., and Oesch, F. 1993. Isolation and characterisation of a cDNA encoding rat liver cytoso- lic epoxide hydrolase and its functional expression in Escherichia coli. J. Biol. Chem. 268: 17623–17627.
   Web of Science ®Google Scholar
• Bell, P. A. and Kasper, C. B. 1993. Expression of rat microsomal epoxide hydrolase in Escherichia coli. J.Biol.Chem. 268: 14011–14017.
   Google Scholar
• Lawton, M. P. and Philpot, R. M. 1993. Functional characterization of flavin-containing monooxygenase 1B1 expressed in Saccharomyces cerevisiae and Es- cherichia coli and analysis of proposed FAD-and membrane-binding domains. J. Biol. Chem. 268: 5728– 5734.
   PubMed Web of Science ®Google Scholar
• Rettie, A. E., Lawton, M. P., Jafar, A., Sadeque, M., Meier, G. P., and Philpot, R.M. 1994. Prochiral sulfoxidation as a probe for multiple forms of the microsomal flavin-containing monooxygenase: stud- ies with rabbit FMO1, FMO2, FMO3, and FMO5 expressed in Escherichia coli. Arch. Biochem. Biophys. 311: 369–377.
   Google Scholar
• Overby, L. H., Buckpitt, A. R., Lawton, M. P., Atta- Asafo-Adjei, E., Schulze, J., and Philpot, R. M. 1995. Characterization of flavin-containig monooxygenase 5 (FMO5) cloned from human and guinea pig: evi- dence that the unique catalytic properties of FMO5 are not confined to the rabbit ortholog. Arch. Biochem. Biophys. 317: 275–284.
   PubMed Web of Science ®Google Scholar
• Itagaki, K., Craver, G. T. and Philpot, R. M. 1996. Expression and characterization of a modified flavin- containing monooxygenase 4 from humans. J. Biol. Chem. 271, 20102–20107. Falls, J. G., Cherrington, N. J., Clements, K. M., Philpot, R. M., Levi, P. E., Rose, R. L., and Hodgson, E. 1997. Molecular cloning, sequencing and expression in Es- cherichia coli of mouse flavin-containing monooxygenase 3 (FMO3): comparison with the hu- man isoform. Arch. Biochem. Biophys. 347: 9–18.
   Google Scholar
• Chen, H. H., Ma, J-X., Forrest, G. L., Deng, P. S. K., Martino, P. A., Lee, T. D., and Chen S. 1992. Expres- sion of rat liver NAD(P)H: quinone-acceptoroxi- doreductase in Escherichia coli and mutagenesis in vitro at Arg-177. Biochem. J. 284: 855–860.
   PubMed Web of Science ®Google Scholar
• Chen, S., Knox, R., Lewis, A. D., Friedlos, F., Work- man, P., Deng, P. S. K., Fung, M., Ebenstein, D. Wu, K., and Tsai, T-M. 1995. Catalytic properties of NAD(P)H: quinoneacceptor oxidoreductase: study involving mouse, rat, human and mouse-rat chimeric enzymes. Molec. Pharmacol. 47: 934–939.
   PubMed Web of Science ®Google Scholar
• Wu, K., Knox, R., Sun, X. Z., Joseph, P., Jaiswal, A. K., Zhang, D., Deng, P. S. K., and Chen, S. 1997. Cata- lytic properties of NAD(P)H: quinoneoxidoreductase- 2 (NQO2) a dihydronicotinamide riboside-dependent oxidoreductase. Arch. Biochem. Biophys. 347: 221– 228.
   PubMed Web of Science ®Google Scholar
• Ouzinne, M., Pillot, T., Fournel-Gigleux, S., Magdalou, J., Burchell, B., and Siest, G. 1994. Expression and the role of the human liver UDPgluc- uronosyltransferase UGT1*6 analyzed by specific antibodies raised against a hybrid protein produced in Escherichia coli. Arch. Biochem. Biophys. 310: 196– 204.
   Google Scholar
• Guengerich, F. P. 1998. The Environmental Genome Project: functional analysis of polymorphisms. Environ. Health Persect. 106: 365–368.
   PubMed Web of Science ®Google Scholar
• Parikh, A., Josephy, P. D. and Guengerich, F. P. 1999. Selection and characterization of human cytochrome P450 1A2 mutants with altered catalytic properties. Biochemistry 38: 5283–5289.
   PubMed Web of Science ®Google Scholar
• Mohn, G. R., Kerklaan, P. R. M., Zeeland, A. A., Ellenberger, J., Baan, R. A., Lohman, P. H. M., and Pons, F-W. 1984. Methodologies for the determina- tion of various genetic effects in permeable strains of E. coli K-12 differing in DNA repair capacity. Mutat. Res. 125: 153–184.
   PubMed Web of Science ®Google Scholar
• Venitt, S., Crofton-Sleigh, C., and Forrester, R. 1984. Bacterial mutation assays using reverse mutation. In: Venitt, S. and Parry, J.M., Eds., Mutagenicity Testing, A Pratical Approach. Chap. 3, Oxford, IRL Press, pp. 45–98.
   Google Scholar